File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Reply to: “Prediction of HBsAg loss after cessation of entecavir therapy”

TitleReply to: “Prediction of HBsAg loss after cessation of entecavir therapy”
Authors
Issue Date1-Mar-2025
PublisherElsevier
Citation
Journal of Hepatology, 2025, v. 82, n. 3, p. e130-e131 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/359640
ISSN
2023 Impact Factor: 26.8
2023 SCImago Journal Rankings: 9.857

 

DC FieldValueLanguage
dc.contributor.authorHui, Rex Wan Hin-
dc.contributor.authorMak, Lung Yi-
dc.contributor.authorYuen, Man Fung-
dc.date.accessioned2025-09-09T00:45:41Z-
dc.date.available2025-09-09T00:45:41Z-
dc.date.issued2025-03-01-
dc.identifier.citationJournal of Hepatology, 2025, v. 82, n. 3, p. e130-e131-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/359640-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofJournal of Hepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleReply to: “Prediction of HBsAg loss after cessation of entecavir therapy”-
dc.typeArticle-
dc.identifier.doi10.1016/j.jhep.2024.10.041-
dc.identifier.pmid39515423-
dc.identifier.scopuseid_2-s2.0-85212700095-
dc.identifier.volume82-
dc.identifier.issue3-
dc.identifier.spagee130-
dc.identifier.epagee131-
dc.identifier.issnl0168-8278-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats